Clinical TrialsSearch results
Number of results: 604
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Phase III, Double-blind, Randomised Study to Assess Switching to AZD9833 (a Next Generation, Oral SERD) + CDK4/6 Inhibitor (Palbociclib or Abemaciclib) vs Continuing Aromatase Inhibitor (Letrozole or Anastrozole)+ CDK4/6 Inhibitor in HR+/HER2-MBC Patients With Detectable ESR1Mutation Without Disease Progression During 1L Treatment With Aromatase Inhibitor+ CDK4/6 Inhibitor- A ctDNA Guided Early Switch Study
- ER-Positive HER2-Negative Breast Cancer
- Hibi Kazusihge
- 2021-09-07
Recruiting
- Phase 2 Dose-finding UC Study
- Ulcerative Colitis, Colitis, Ulcerative, IBD
- Ageishi Yuji
- 2021-08-30
Recruiting
- Study for the effects of once-daily semaglutid on glycemic control in patients with type 2 diabetes (SWITCH SEMA-2 study)
- type 2 diabetes
- Nomoto Hiroshi
- 2021-08-26
Recruiting
- A multicenter study to investigate Oral JAK inhibitor Pharmacogenomics and Exposure-Response relationship in Japanese adult patients with moderately to severely Active ulcerative colitis during the COVID-19 pandemic
- Ulcerative Colitis
- Fukudo Masahide
- 2021-08-23
Other
- A study of FSN-013 in Japanese patients with endometriosis
- endometriosis
- Takayanagi Toshiaki
- 2021-08-06
Recruiting
- A Study of KRN125 in patients with multiple myeloma and malignant lymphoma
- multiple myeloma and malignant lymphoma
- Shimogomi Aiko
- 2021-08-06
Recruiting
- Phase 3 Trial of Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer
- Cervical cancer
- Jain Shweta
- 2021-08-06
Not yet recruiting
- A comparative study of the effect of propofol and remimazolam on blood pressure during general anesthesia
- pancreatic cancer, hepatic cancer, bladder cancer, colon cancer, gastric cancer
- Tomohiro Chaki
- 2021-07-30
Recruiting
- A Study of Bortezomib, Lenalidomide and Dexamethasone (VRd) followed by Cilta-cel, a CAR-T Therapy Directed Against BCMA versus VRd followed by Lenalidomide and Dexamethasone (Rd) Therapy in Participants with Newly Diagnosed Multiple Myeloma for Whom ASCT is Not Planned as Initial Therapy
- Multiple Myeloma
- Fujikawa Ei
- 2021-07-30
Other
- A study of FSN-013 in Japanese patients with dysmenorrhea
- dysmenorrhea
- Takayanagi Toshiaki
- 2021-07-28